CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

444 hedge funds and large institutions have $3.47B invested in CRISPR Therapeutics in 2022 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 170 increasing their positions, 97 reducing their positions, and 65 closing their positions.

Holders
444
Holders Change
–
Holders Change %
0%
% of All Funds
7.03%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
72
Increased
170
Reduced
97
Closed
65
Calls
$149M
Puts
$156M
Net Calls
-$6.94M
Net Calls Change
-$24M

Top Buyers

1
Sumitomo Mitsui Trust Group
1
Sumitomo Mitsui Trust Group
Japan
$290M
2
BlackRock
2
BlackRock
New York
$143M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$79.2M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$76.4M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$41.6M

Top Sellers

1
EC
1
EcoR1 Capital
California
$0
2
Capital World Investors
2
Capital World Investors
California
$0
3
Jennison Associates
3
Jennison Associates
New York
$0
4
American Century Companies
4
American Century Companies
Missouri
$0
5
Millennium Management
5
Millennium Management
New York
$2.87M
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$590M 9,404,071 +316,203 +3%
NMC
2
NEA Management Company
Maryland
$366M 1,590,002 – –
NAMA
3
Nikko Asset Management Americas
New York
$291M 4,619,747 +300,276 +7%
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$290M 4,619,747 +4,619,747 New
Capital International Investors
5
Capital International Investors
California
$226M 3,602,152 +10,992 +0.3%
BlackRock
6
BlackRock
New York
$143M 2,278,774 +1,007,246 +79%
Loomis, Sayles & Company
7
Loomis, Sayles & Company
Massachusetts
$81M 1,290,905 -25,218 -2%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$79.2M 1,261,622 +890,900 +240%
Vanguard Group
9
Vanguard Group
Pennsylvania
$76.4M 1,217,289 +880,463 +261%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$73.2M 1,166,114 +75,301 +7%
AC
11
Armistice Capital
New York
$64.3M 1,024,000 +132,000 +15%
CS
12
Credit Suisse
Switzerland
$63.9M 1,017,827 -75,625 -7%
BG
13
Bellevue Group
Switzerland
$58.2M 926,905 -47,779 -5%
Bank of America
14
Bank of America
North Carolina
$45.6M 725,949 +260,739 +56%
Renaissance Technologies
15
Renaissance Technologies
New York
$44.1M 702,300 +123,458 +21%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$41.6M 663,089 +596,823 +901%
JPMorgan Chase & Co
17
JPMorgan Chase & Co
New York
$40.6M 646,572 -125,327 -16%
Norges Bank
18
Norges Bank
Norway
$38.5M 613,833 +21,096 +4%
Federated Hermes
19
Federated Hermes
Pennsylvania
$36.5M 580,918 – –
Allspring Global Investments
20
Allspring Global Investments
North Carolina
$34.6M 551,564 +264,969 +92%
Morgan Stanley
21
Morgan Stanley
New York
$32.5M 517,388 -26,122 -5%
VVM
22
Versant Venture Management
California
$31.3M 498,558 – –
State Street
23
State Street
Massachusetts
$30M 477,476 +269,824 +130%
Voloridge Investment Management
24
Voloridge Investment Management
Florida
$23.8M 379,234 +163,605 +76%
Charles Schwab
25
Charles Schwab
California
$22.3M 354,803 +354,803 New
1
2 3 4 5